Abstract
Multiple sclerosis (MS) is a chronic and demyelinating disease of the central nervous system (CNS). MS immunophatogenesis involves Th1, Th17 and Tc autoreactive lymphocytes and also macrophages and microglial cells activation that release many pro-inflammatory mediators and free radicals. Current therapies do not determine disease cure and some subjects are refractory to therapies. Theref…